GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024
ATLANTA, GA, Dec. 27, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – GeoVax Labs, Inc. (Nasdaq:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that David Dodd, Chief Executive Officer, will present at the Biotech Showcase coinciding with the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, January 8-11, 2024.
Related news for (GOVX)
- Breaking News: MoBot’s Latest Update as of 07/08/25 03:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 06/18/25 04:00 AM
- MoBot alert highlights: NASDAQ: TMC, NASDAQ: URGN, NASDAQ: NCPL, NASDAQ: EYEN, NASDAQ: GOVX (06/16/25 03:00 PM)
- MoBot’s Stock Market Highlights – 06/16/25 11:00 AM
- GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster